Frazier Life Sciences is a dedicated healthcare-focused fund with a new 5.9% passive stake. No activist conversion is unlikely given the 13G certification. Monitor for any subsequent 13D filing or material changes in ownership.
Price Chart
Executive Summary
Frazier Life Sciences Public Fund, L.P. filed a new Schedule 13G disclosing a 5.9% passive stake in Q32 Bio Inc., holding 1,755,116 shares as of October 2, 2026. This is a new filing (not an amendment) by a dedicated healthcare fund, indicating a meaningful but non-activist position in the clinical-stage biotech.
Key Financial Metrics
Key Facts
- Frazier Life Sciences Public Fund, L.P. filed a new Schedule 13G on October 9, 2026
- Beneficial ownership: 1,755,116 shares of common stock, representing 5.9% of shares outstanding
- Percentage based on 29,769,466 shares outstanding as of August 3, 2026 (per Q32 Bio's 10-Q filed August 5, 2026)
- Filing is a new position, not an amendment to a prior filing
- Filing certifies passive intent — no intent to change or influence control of the issuer
- Additional related funds in the group: FLS XI (23,116 shares), FLS XII (125,039) also hold small positions
- Filing is a passive 13G, not a 13D activist filing
Financial Impact
5.9% passive stake valued at undisclosed amount; no transaction price or total value disclosed in filing
Risk Factors
- Frazier may increase or decrease position without further disclosure until next 13G amendment threshold
- Clinical-stage biotech with no approved products; stake size does not guarantee future support
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001231919-26-001441 |
| Document: 0001231919-26-001441-index-headers.html | 0001231919-26-001441 |
| Document: 0001231919-26-001441-index.html | 0001231919-26-001441 |
| Document: 0001231919-26-001441.txt | 0001231919-26-001441 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | SC 13G | $8.74 $7.79 | ▼ −10.87% | ▼ −9.38% | $8.71 (−0.34%) |
Sep 30, 2026 27d ago | 8-K | $8.27 $7.99 | ▼ −3.39% | ▼ −5.30% | $8.71 (+5.32%) |
Sep 14, 2026 6w ago | 8-K | $10.91 $10.47 | ▼ −4.03% | ▼ −4.14% | $8.71 (−20.16%) |
Aug 27, 2026 8w ago | Insider Cluster | $15.03 $11.99 | ▼ −20.23% | ▼ −20.34% | $8.71 (−42.05%) |
Aug 5, 2026 11w ago | 8-K | $16.49 $15.37 | ▼ −6.79% | ▼ −7.14% | $8.71 (−47.18%) |
Jul 14, 2026 14w ago | Press Release | $15.70 $15.08 | ▲ +3.95% | ▲ +2.97% | $8.71 (+44.52%) |
Jul 14, 2026 15w ago | EFFECT | $18.46 $15.04 | ▼ −18.53% | ▼ −17.23% | $8.71 (−52.82%) |
Jul 13, 2026 15w ago | 8-K | $21.38 $15.05 | ▼ −29.61% | ▼ −28.82% | $8.71 (−59.26%) |
Jul 13, 2026 15w ago | 8-K | $21.38 $15.05 | ▼ −29.61% | ▼ −28.82% | $8.71 (−59.26%) |
Jun 25, 2026 17w ago | S-3 | $13.17 $13.09 | ▼ −0.61% | ▼ −2.77% | $8.71 (−33.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers